Sofosbuvir Initial Therapy Abandonment and Manufacturer Coupons in a Commercially Insured Population
Member cost negatively affects initial medication adherence and manufacturer coupons can decrease member share by up to 98%.
Kirsten Tiberg, RPh
Advertisement
Articles by Kirsten Tiberg, RPh
Advertisement
Latest Updated Articles
- Sofosbuvir Initial Therapy Abandonment and Manufacturer Coupons in a Commercially Insured Population
Published: May 3rd 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
4
US, Japan Patients With Diabetes Discontinue Semaglutide After First Year
5
